---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-006040"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2025-02-12T23:59:59+00:00"
generated_at: "2026-05-26T23:03:01.176957+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "medium"
source: SEC EDGAR
---

# Mangoceuticals announces study on avian flu prevention in poultry using water-based antiviral solution

## Summary
- Engaged Vipragen Biosciences for efficacy studies on H5N1 prevention via drinking water solution.
- Phase I animal studies showed significant reduction in lung viral load; Phase II ongoing.
- Solution uses GRAS ingredients; aims to offer non-pharmaceutical preventive tool.
- Avian flu outbreak led to culling of >148M birds in U.S. since 2022; egg prices hit $4.15/dozen Dec 2024.
- Global poultry market projected at $375.41B by 2030; company to share final study results upon completion.

## SEC filing metadata
- accession: 0001493152-25-006040
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2025-02-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: medium
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000149315225006040/0001493152-25-006040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000149315225006040/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-006040
- JSON: https://secwatch.observer/filing/0001493152-25-006040.json
- Plain text: https://secwatch.observer/filing/0001493152-25-006040.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.